Immune checkpoint inhibitor related myositis: an observational, retrospective, pharmacovigilance study

CONCLUSIONS: Clinicians should be aware of the potential for ICI-associated myositis, as it can be particularly life-threatening, especially in elderly patients or when it occurs concurrently with other AEs such as myocarditis or severe myasthenia gravis.PMID:38629402 | DOI:10.1080/14740338.2024.2343023
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Source Type: research